Namzaric (memantine and donepezil hydrochlorides) Extended-release

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Anesthesia Cardiovascular Conditions donepezil hydrochloride, (addition of an active...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts